Impact of smoking on estrogenic efficacy

References

• Hartz AJ, He T. Cohort study of risk factors for breast cancer in postmenopausal women. Epidemiol Health 2013; Apr 30; 35:e2013003. doi: 10.4178/epih/e2013003
   PubMedGoogle Scholar
• Gao CM, Ding JH, Li SP, et al. Active and passive smoking, and alcohol drinking and breast cancer risk in Chinese women. Asian Pac J Cancer Prev 2013;14:993–6
   PubMed Web of Science ®Google Scholar
• Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:312–33
   PubMedGoogle Scholar
• Rosenberg L, Boggs DA, Bethea TN, Wise LA, Adams-Campbell LL, Palmer JR. A prospective study of smoking and breast cancer among African women. Cancer Causes Control 2013;24: 2207–15
   PubMed Web of Science ®Google Scholar
• Reynolds P. Smoking and breast cancer. J Mammary Gland Biol Neoplasia 2013;18:15–23
   PubMed Web of Science ®Google Scholar
• Luo J, Margolis KL, Wactawski-Wende J, et al. Association of active and passive smoking with risk of breast cancer among postmenopausal women: a prospective cohort study. BMJ 2011; Mar 1, 342:d1016; doi: 10.1136/bmj.d1016
   PubMed Web of Science ®Google Scholar
• Hu FB, Stampfer MJ, Manson JE, et al. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. N Engl J Med 2000;343:530–7
   PubMed Web of Science ®Google Scholar
• Polesel J, Serraino D, Zucchetto A, et al. Cigarette smoking and endometrial cancer risk: the modifying effect of obesity. Eur J Cancer Prev 2009;18:476–81
   PubMed Web of Science ®Google Scholar
• Duskova M, Simunkova K, Hill M, et al. Chronic cigarette smoking alters circulating sex hormones and neuroactive steroids in premenopausal women. Phyiol Res 2012;61:97–111
   PubMed Web of Science ®Google Scholar
• Gu F, Caporaso NE, Schairer C, et al. Urinary concentrations of estrogens and estrogen metabolites and smoking in Caucasian women. Cancer Epidemiol Biomarkers Prev 2013;22:58–68
   PubMed Web of Science ®Google Scholar
• Michnovicz JJ, Hershcopf RJ, Naganuma H, et al. Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N Engl J Med 1986; 315:1305–9
   PubMed Web of Science ®Google Scholar
• Michnovicz JJ, Naganuma H, Hershcopf RJ, et al. Increased urinary catechol estrogen excretion in female smokers. Steroids 1988;52:69–83
   PubMedGoogle Scholar
• Cramer DW, Huijuan X. Predicting age at menopause. Maturitas 1996;23:319–26
   PubMed Web of Science ®Google Scholar
• Friedman AJ, Ravnikar VA, Barbieri RI. Serum steroid hormone profiles in postmenopausal smokers and nonsmokers. Fertil Steril 1987;47:398–401
   PubMed Web of Science ®Google Scholar
• Lesko SM, Rosenberg L, Kaufman DW, et al. Cigarette smoking and risk of endometrial cancer. N Engl J Med 1985; 313:593–6
   PubMed Web of Science ®Google Scholar
• Zhou B, Yang L, Sun Q, et al. Cigarette smoking and the risk of endometrial cancer: a meta-analysis. Am J Med 2008; 121:501–8
   PubMed Web of Science ®Google Scholar
• Olsson H, Bladström A, Ingvar C. Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy? Obstet Gynecol 2003;102:565–70
   PubMed Web of Science ®Google Scholar
• Ross RK, Pike MC, Vesey MP. Risk factors for uterine fibroids. Br Med J 1986;293:359–62
   PubMed Web of Science ®Google Scholar
• Cramer DW, Wilson E, Stillman RJ, et al. The relationship of endometriosis to menstrual characteristics, smoking and exercise. JAMA 1986;255:1904–8
   PubMed Web of Science ®Google Scholar
• Bjarnason NH, Jorgensen C, Kremmer H, Alexandersen P, Christiansen C. Smoking reduces breast tenderness during oral estrogen-progestogen therapy. Climacteric 2004, 7:390–6
   PubMed Web of Science ®Google Scholar
• Wallwiener C, Wallwiener L-M, Seeger H, Mueck AO, Bitzer J, Wallwiener M. Prevalence of sexual dysfunction and impact of contraception in female German medical students. J Sex Med 2010;7:2139–48
   PubMed Web of Science ®Google Scholar
• Wallwiener M, Wallwiener L-M, Seeger H, Mueck AO, Bitzer J, Wallwiener CW. Effects of sex hormones in oral contraceptives on the female sexual function score: a study in German female medical students. Contraception 2010;82:155–9
   PubMed Web of Science ®Google Scholar
• Cochran CJ, Gallicchio L, Miller SR, Zacur H, Flaws JA. Cigarette smoking, androgen levels, and hot flushes in midlife women. Obstet Gynecol 2008;112:1037–44
   PubMed Web of Science ®Google Scholar
• Thompson PA, Ambrosone C. Molecular epidemiology of genetic polymorphisms in estrogen metabolizing enzymes in human breast cancer. J Natl Cancer Inst Monogr 2000;27:125–34
   PubMedGoogle Scholar
• Saintot M, Malaveille C, Hautefeuille A, Gerber M. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk. Int J Cancer 2003;107:652–7
   PubMed Web of Science ®Google Scholar
• Ishibe N, Hankinson SE, Colditz GA, et al. Cigarette smoking, cytochrome P450 1A1 polymorphism, and breast cancer risk in the Nurses’ Health Study. Cancer Res 1998;58:667–71
   PubMed Web of Science ®Google Scholar
• Bjarnason NH, Byrjalsen I, Jorgensen HL, Christiansen C. The influence of smoking on uterine bleeding during sequential oral hormone therapy. Climacteric 2007;10:147–54
   PubMed Web of Science ®Google Scholar
• Bumb RC, McClish DK. Cigarette smoking and urinary incontinence. Am J Obstet Gynecol 1992;167:1213–18
   PubMed Web of Science ®Google Scholar
• Jensen J, Christiansen C. Effects of smoking on serum lipoproteins and bone mineral content during postmenopausal hormone replacement therapy. Am J Obstet Gynecol 1988;159:820–5
   PubMed Web of Science ®Google Scholar
• Bjarnason NH, Jorgensen HL, Christiansen C. Acute and long-term estradiol kinetics in smoking postmenopausal women. Climacteric 2012;15:449–54
   PubMed Web of Science ®Google Scholar
• Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentration: an analysis of published data. Br Med J 1989;298:784–8
   PubMed Web of Science ®Google Scholar
• Baron JA, Farahmand BY, Weiderpass E, et al. Cigarette smoking, alcohol consumption, and risk of hip fracture in women. Arch Intern Med 2001;161:983–8
   PubMed Web of Science ®Google Scholar
• Callreus M, McGuigan F, Akesson K. Adverse effects of smoking on peak bone mass may be attenuated by higher body mass index in young female smokers. Calcif Tissue Int 2013;93:517–25
   PubMed Web of Science ®Google Scholar
• Brook JS, Balka EB, Zhang C. The smoking patterns of women in their forties: their relationship to later osteoporosis. Psychol Rep 2012;110:351–62
   PubMed Web of Science ®Google Scholar
• Iqbal J, Sun L, Cao J, et al. Smoke carcinogens cause bone loss through the aryl hydrocarbon receptor and induction of Cyp1 enzymes. Proc Natl Acad Sci USA 2013;110:11115–20
   PubMed Web of Science ®Google Scholar
• Yoon V, Maalouf NM, Sakhaee K. The effects of smoking on bone metabolism. Osteoporos Int 2012;23:2081–92
   PubMed Web of Science ®Google Scholar
• Jensen J, Christiansen C, Rodbror P. Cigarette smoking, serum estrogen, and bone loss during hormone replacement therapy early after menopause. N Engl J Med 1985;313:973–5
   PubMed Web of Science ®Google Scholar
• Kiel DP, Baron JA, Anderson JJ, et al. Smoking eliminates the protective effect of oral estrogen on the risk for hip fracture among women. Ann Intern Med 1992;116:716–21
   PubMed Web of Science ®Google Scholar
• Komulainen M, Kroeger H, Tuppurainen MT, et al. Oral estradiol – identification of early postmenopausal women with no bone response to HRT. Osteoporos Int 2000;11:211–18
   PubMed Web of Science ®Google Scholar
• Leino A, Impivaara O, Kaitsaari M. Effects of HRT on bone in women smokers and alcohol consumers. J Bone Miner Res 1997;12:S355
   Google Scholar
• Valk-de Roo GW, Netelenbos JC, Peters-Muller IRA, et al. Continuously combined hormone replacement therapy and bone turnover: the influence of dydrogesterone dose, smoking and initial degree of bone turnover. Maturitas 1997;28:153–62
   PubMed Web of Science ®Google Scholar
• Cubrilo-Turek M, Stavljenic-Rukavina A, Turek S, et al. The usefulness of biochemical markers in predicting the response of hormone replacement therapy in perimenopausal smoking healthy women. Coll Antropol 1999;23:195–201
   PubMed Web of Science ®Google Scholar
• Modena MG, Sismondi P, Mueck AO, et al.; The TREAT Collaborative Group. New evidence regarding hormone replacement therapies is urgently required. Transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits. Maturitas 2005;52:1–10
   PubMed Web of Science ®Google Scholar
• Girdler SS, Hinderliter AL, West SG, et al. Postmenopausal smokers show reduced hemodynamic benefit from oral hormone replacement. Am J Cardiol 2000;86:590–2
   PubMed Web of Science ®Google Scholar
• Ylikorkala O, Cacciatore B, Paakari I, et al. The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane. Fertil Steril 1998;69:883–8
   PubMed Web of Science ®Google Scholar
• Geisler J, Omsjo IH, Helle SI, et al. Plasma oestrogen fractions in postmenopausal women receiving hormone replacement therapy: influence of route of administration and cigarette smoking. J Endocrinol 1999;162:265–70
   PubMed Web of Science ®Google Scholar
• Wilson PWF, Garrison RJ, Castelli WP. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. N Engl J Med 1985;313: 1038–43
   PubMed Web of Science ®Google Scholar
• Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiologic studies with 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047–59
   PubMed Web of Science ®Google Scholar
• Palmer JR, Rosenberg L. Cigarette smoking and the risk of breast cancer. Epidemiol Rev 1993;15:145–56
   PubMed Web of Science ®Google Scholar
• Khuder SA, Mutgi AB, Nugent S. Smoking and breast cancer: a meta-analysis. Rev Environ Health 2001;16:253–61
   PubMedGoogle Scholar
• Reynolds P. Smoking and breast cancer. J Mammary Gland Biol Neoplasia 2013;18:15–23
   PubMed Web of Science ®Google Scholar
• Kuhl H. Breast cancer risk in the WHI study: The problem of obesity. Maturitas 2005;51:83–97
   PubMed Web of Science ®Google Scholar
• Luo J, Horn K, Ockene JK, et al. Interaction between smoking and obesity and the risk of developing breast cancer among postmenopausal women: the Women’s Health Initiative observational study. Am J Epidemiol 2011;174:919–28
   PubMed Web of Science ®Google Scholar
• Band PR, Le ND, Fang R, Deschamps M. Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. Lancet 2002;360:1044–9
   PubMed Web of Science ®Google Scholar
• Glantz SA, Johnson KC. The Surgeon General report on smoking and health 50 years later: breast cancer and the cost of increasing caution. Cancer Epidemiol Biomarkers Prev 2014;23:37–46
   PubMed Web of Science ®Google Scholar
• WHI Investigators Writing Group. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. JAMA 2003;289:3243–53
   PubMed Web of Science ®Google Scholar
• Manjer J, Johansson R, Lenner P. Smoking is associated with postmenopausal breast cancer in women with high levels of estrogens. Int J Cancer 2004;112:324–8
   PubMed Web of Science ®Google Scholar
• Mueck AO, Ruan X. Benefits and risks during HRT – main safety issue breast cancer. Horm Mol Biol Clin Invest 2011; 5:105–16
   PubMedGoogle Scholar
• Stanczyk FZ. Editorial. Can the increase in breast cancer observed in the estrogen plus progestin arm of the Women’s Health Initiative trial be explained by progesterone receptor membrane component 1? Menopause 2011;18:833–4
   PubMed Web of Science ®Google Scholar
• Neubauer H, Ma Q, Zhou J, et al. Possible role of PGRMC1 in breast cancer development. Climacteric 2013;16:509–13
   PubMed Web of Science ®Google Scholar
• Ruan X, Neubauer H, Yang Y, et al. Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells. Climacteric 2012;15:467–72
   PubMed Web of Science ®Google Scholar
• Russo J, Russo IH. The role of the basal stem cell of the human breast in normal development and cancer. Adv Exp Med Biol 2011;720:121–34
   PubMed Web of Science ®Google Scholar
• Di Cello F, Flowers VL, Li H, et al. Cigarette smoke induces epithelial to mesenchymal transition and increases the metastatic ability of breast cancer cells. Mol Cancer 2013;12:90
   PubMedGoogle Scholar
• Behera SN, Xian H, Balasubramanian R. Human health risk associated with exposure to toxic elements in mainstream and sidestream cigarette smoke. SciTotal Environ 2014;472: 947–56
   PubMed Web of Science ®Google Scholar
• Service RF. New role for estrogen in cancer? Science 1998; 279:1631–3
   PubMed Web of Science ®Google Scholar
• Schneider HPG, Mueck AO, Kuhl H. IARC Monographs on carcinogenicity of combined hormonal contraceptives and menopausal therapy. Climacteric 2005;8:311–16
   PubMed Web of Science ®Google Scholar
• Mueck AO, Seeger H. Breast cancer: are estrogen metabolites carcinogenic? Climacteric 2007;10(Suppl 2):62–5
   PubMed Web of Science ®Google Scholar
• Mueck AO, Seeger H. The World Health Organization defines HRT as carcinogenic – is this plausible? Gynecol Endocrinol 2008;24:129–32
   PubMed Web of Science ®Google Scholar
• Seeger H, Wallwiener D, Krämer E, Mueck AO. Comparison of possible carcinogenic estradiol metabolites: Effects on proliferation, apoptosis and metastasis of human breast cancer cells. Maturitas 2006;54:72–7
   PubMed Web of Science ®Google Scholar
• Berstein LM, Tsyrlina EV, Kolesnik OS, et al. Catecholestrogens excretion in smoking and non-smoking postmenopausal women receiving estrogen replacement therapy. J Steroid Biochem Mol Biol 2000;72:143–7
   PubMed Web of Science ®Google Scholar
• Lippert TH, Seeger H, Mueck AO. Pharmacology and toxicology of different estrogens. Gynecol Endocrinol 2001; 15(Suppl 4):26–33
   Google Scholar
• Lippert TH, Seeger H, Mueck AO. The impact of estrogen metabolites on carcinogenesis. Steroids 2000;65:357–69
   PubMed Web of Science ®Google Scholar
• Lippert TH, Seeger H, Mueck AO. In Oettel M, Schillinger E, eds. Handbook of Experimental Pharmacology, Vol. 135/I: Estrogens and antiestrogens. Heidelberg, New York: Springer, 1999:243–71
   Google Scholar
• Mueck AO, Seeger H, Lippert TH. Estradiol metabolism and malignant disease. Maturitas 2002;43:1–10
   PubMed Web of Science ®Google Scholar
• Lippert TH, Seeger H, Mueck AO. Estrogens and the cardiovascular system: role of estradiol metabolites in hormone replacement therapy. Climacteric 1999;1:296–301
   Google Scholar
• Mueck AO, Seeger H. 2-Methoxyestradiol – biology and mechanism of action. Steroids 2010;75:625–31
   PubMed Web of Science ®Google Scholar
• Seeger H. Mueck AO, Lippert TH. Estradiol metabolism during oral and transdermal estradiol replacement therapy in the postmenopause. Horm Metab Res 1998;30:598–601
   PubMed Web of Science ®Google Scholar
• Seeger H, Mueck AO, Lippert TH. Effect of norethisterone acetate on estrogen metabolism in postmenopausal women. Horm Metab Res 2000;32:436–9
   PubMed Web of Science ®Google Scholar
• Mueck AO, Seeger H, Gräser T, Lippert TH. Effect of postmenopausal HRT and of oral contraceptives on estradiol metabolism. Horm Metab Res 2001;33:744–7
   PubMed Web of Science ®Google Scholar